A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options could extend overall survival (OS) to 16.9 months according to ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...

Kate thanked staff at the Royal Marsden Hospital As she thanked staff and comforted patients at the hospital, the royal also opened about her "really tough" chemotherapy and joked about becoming ...

A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs – gemcitabine and ...

Kate, 43, first revealed her diagnosis of an unspecified type of cancer in March 2024 and announced she had completed chemotherapy in September. After her hospital visit, she shared the news that ...

Heartbroken Coleen Nolan previously showered her 'absolute warrior' sister Linda with praise saying she 'treats chemo like going to Tesco'. Linda Nolan died on Wednesday with her famous sisters ...

If your chemo treatment is causing hair loss, you may consider wigs. You can try a human hair or synthetic wig. Different wig caps, such as lace front, monofilament, or hand-tied, come at ...

For many people, chemo is one of those necessary evils. It’s a treatment that – while sometimes highly unpleasant – is one of the main options during a cancer diagnosis. And while that can be ...

Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition ...

Libtayo may be used in combination with chemotherapy that contains a platinum medicine as your first treatment when your lung cancer has not spread outside your chest (locally advanced lung cancer) ...